NCT06590298View on ClinicalTrials.gov

Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

April 10, 2025

Conditions

PsychosisMetabolic SyndromeWeight Gain

Interventions

DRUG

Adjunctive Aripiprazole for improving Weight and Metabolic Outcomes in Females

The intervention group will be added 5 mg of aripiprazole as an adjunct with the usual antipsychotic treatment to the females on antipsychotic treatment

All Listed Sponsors

lead

Universiti Putra Malaysia

OTHER

NCT06590298 - Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females | Biotech Hunter | Biotech Hunter